Dihydroberberine

Overview

Dihydroberberine is a naturally occurring isoquinoline alkaloid derived from the reduction of berberine, a compound found in various plants such as those in the Berberidaceae family.¹² It has the molecular formula C₂₀H₁₉NO₄ and a molecular weight of 337.37 g/mol, appearing as yellow crystals with limited water solubility but good solubility in DMSO.³⁴⁵ Primarily classified as a metabolic health supplement, it is researched for its enhanced bioavailability compared to berberine, targeting glucose and lipid metabolism.² Traditionally, berberine derivatives like dihydroberberine have been used in herbal medicine for digestive and antimicrobial purposes, with modern interest stemming from their potential in managing metabolic disorders such as diabetes and cardiovascular conditions.²

Forms and Variations

Dihydroberberine is most commonly available as a pure powdered compound (CAS 483-15-8) for laboratory and supplement use, often supplied by chemical suppliers as reference standards with purity ≥90-95% via HPLC.³⁶ It exists in crystalline form, yellow in color, and is synthesized by reducing berberine chloride using sodium borohydride in alkaline methanol.⁴ Variations include phyproof reference substances for analytical purposes.⁶ Pharmaceutical formulations may combine it with solubility enhancers like DMSO, PEG300, Tween 80, or corn oil for in vivo studies due to its poor water solubility (57.46 mg/L).¹³ Choose high-purity forms for research accuracy and stability; store sealed at -20°C away from moisture and light to prevent degradation.¹

Dosage and Administration

Specific human dosage recommendations for dihydroberberine as a supplement are not well-established due to limited clinical data, but research contexts use concentrations like 3.37 mg/mL in DMSO for in vitro studies.³ For in vivo formulations, prepare master liquids in DMSO then dilute stepwise with PEG300, Tween 80, and water or corn oil, ensuring clarity at each step via sonication or vortexing.¹ Typical administration in animal models involves oral or injectable routes post-formulation.¹ Best practices include taking on an empty stomach to mimic metabolic studies, starting low (e.g., equivalent to 100-500 mg berberine-adjusted doses), and monitoring blood glucose due to its metabolic effects.² Always use under professional guidance; avoid exceeding lab-tested concentrations without data.

Scientific Research and Mechanism of Action

Dihydroberberine is studied for its superior absorption over berberine, rapidly converting back to berberine in vivo, which activates AMP-activated protein kinase (AMPK) to improve glucose uptake and insulin sensitivity.² Key research highlights its role in glucose metabolism, lipid regulation, and antioxidant activity, with potential benefits for diabetes and cardiovascular health.² It targets heat shock proteins (HSP), potassium channels, and exhibits higher bioavailability (up to 5-fold) due to its reduced structure.³ Pharmacological studies employ chromatography for analysis, showing effects on metabolic pathways via tetrahydroisoquinoline framework.² Current research is preclinical, focusing on synthesis (e.g., NaBH₄ reduction) and therapeutic applications; human trials are lacking, positioning it as promising but investigational.⁴ Ongoing studies explore its stability (melting point 223-224°C) and density (1.37 g/cm³).⁴

Benefits and Potential Uses

Dihydroberberine shows promise in managing metabolic disorders through enhanced glucose metabolism, reducing blood sugar levels more effectively than berberine due to better absorption.² It supports lipid metabolism, potentially lowering cholesterol and triglycerides, beneficial for cardiovascular health.² Antioxidant properties protect against oxidative stress, aiding in diabetes prevention and management.² Research indicates uses in obesity, insulin resistance, and related conditions by influencing energy homeostasis via AMPK activation.² Its role in HSP and potassium channel modulation suggests neuroprotective potential, though unproven clinically.³ Plant-derived nature supports traditional applications for gut health, but evidence is preliminary. Specific conditions addressed include type 2 diabetes, hyperlipidemia, and metabolic syndrome; benefits are extrapolated from berberine studies with improved pharmacokinetics.²

Side Effects and Risks

Common side effects mirror berberine: gastrointestinal upset like nausea, diarrhea, or constipation, though dihydroberberine"s better absorption may reduce these.² It carries acute oral toxicity (GHS06, H300), classified as very toxic, with risks of severe poisoning if mishandled.⁶ Contraindications include pregnancy, breastfeeding, and liver/kidney impairment due to metabolic processing.² Yellow crystalline form may cause skin/eye irritation in pure powder handling.⁴ Groups cautioned: children, elderly, those with hypotension (due to potential AMPK effects), or on glucose-lowering drugs. Monitor for hypoglycemia; discontinue if adverse reactions occur.²

Interactions and Precautions

Dihydroberberine may interact with antidiabetic medications (e.g., metformin, insulin), amplifying hypoglycemia risk via shared AMPK pathways.² Potential cytochrome P450 inhibition (like berberine) affects drugs like statins, antihypertensives, or anticoagulants.² Avoid with immunosuppressants due to possible immune modulation. Precautions for diabetics (blood sugar monitoring), pregnant/lactating women (insufficient safety data), and those with GI disorders.² Before surgery, stop 2 weeks prior due to blood sugar effects. Handle pure compound with gloves (P264, P270); in case of ingestion, seek immediate medical help (P301+P310).⁶ Consult physician for personalized advice.

Impact on Biomarkers

Dihydroberberine positively influences glucose-related biomarkers, lowering fasting blood glucose and HbA1c via improved insulin sensitivity.² It reduces lipid markers like LDL-cholesterol and triglycerides while potentially raising HDL.² Antioxidant effects may lower oxidative stress markers (e.g., MDA). Monitors AMPK activity indirectly through metabolic panels; track liver enzymes (ALT/AST) for safety.²

Overdose and Toxicity

Over-supplementation risks acute toxicity (LD50 unknown, but Acute Tox. 2 Oral), with symptoms including severe nausea, hypotension, respiratory distress, or coma.⁶ High doses exacerbate GI issues or hypoglycemia. No established safe upper limit; lab solubilities (e.g., 20 mg/mL DMSO) guide research max, but human Tolerable Upper Intake Level absent.¹ Toxicity symptoms: abdominal pain, dizziness; seek emergency care (P405 storage, P501 disposal).⁶ Prevent by adhering to low investigational doses.

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.